Antioxidant capacity of eugenol derivatives
| dc.contributor.author | Hidalgo, María E. | |
| dc.contributor.author | De la Rosa, Carlos | |
| dc.contributor.author | Carrasco, Héctor | |
| dc.contributor.author | Cardona, Wilson | |
| dc.contributor.author | Gallardo, Claudio | |
| dc.contributor.author | Espinoza, Luis | |
| dc.date.accessioned | 2016-07-21T21:06:28Z | |
| dc.date.available | 2016-07-21T21:06:28Z | |
| dc.date.issued | 2009 | |
| dc.description | Indexación: Web of Science; Scielo | es |
| dc.description.abstract | Toxicity and antioxidant capacity of eugenol derivatives (E2 = 2-Methoxy-4-[1-propenylphenyl]acetate, E3 = 4-Allyl-2-methoxyphenylacetate, E4 = 4-Allyl-2-methoxy-4-nitrophenol, E5 = 5-Allyl-3-nitrobenzene-1,2-diol, E6 = 4-Allyl-2-methoxy-5-nitrophenyl acetate) were evaluated in order to determine the influence of the sustituents. E2-E6 were synthesized from eugenol (E1). E1 was extracted from cloves oil, and E2-E6 were obtained through acetylation and nitration reactions. Antioxidant capacity evaluated by DPPH (1, 1-Diphenyl-2-picrylhydrazil) and ORAC fluorescein demonstrated that E1 and E5 have a higher capacity and the minor toxicity evaluated by red blood cells haemolysis and the Artemia saline test. In accordance with our results, the compound's (E1-E5) use in the pharmaceutical, cosmetic and or food industries could be suggested. | es |
| dc.description.uri | http://ref.scielo.org/gtn2wp | |
| dc.identifier.citation | Quím. Nova vol.32 no.6 São Paulo 2009 | es |
| dc.identifier.issn | 0100-4042 | |
| dc.identifier.other | http://dx.doi.org/10.1590/S0100-40422009000600020 | |
| dc.identifier.uri | http://repositorio.unab.cl/xmlui/handle/ria/1132 | |
| dc.language.iso | en | es |
| dc.publisher | Sociedade Brasileira de Química | es |
| dc.subject | Eugenol derivatives | es |
| dc.subject | Antioxidant capacity | es |
| dc.title | Antioxidant capacity of eugenol derivatives | es |
| dc.type | Artículo | es |
Archivos
Bloque original
1 - 1 de 1
Cargando...
- Nombre:
- Hidalgo_ANTIOXIDANT_CAPACITY_OF_EUGENOL_DERIVATIVES.pdf
- Tamaño:
- 168.38 KB
- Formato:
- Adobe Portable Document Format
- Descripción:
- TEXTO COMPLETO INGLES
Bloque de licencias
1 - 1 de 1
No hay miniatura disponible
- Nombre:
- license.txt
- Tamaño:
- 1.71 KB
- Formato:
- Item-specific license agreed upon to submission
- Descripción: